1.
|
The gut microbiome is involved in promoting or inhibiting (protecting against or contributing to the development of) many diseases, such as diabetes, inflammatory bowel d [...]
2023-07-21 |
Abstract |
|
2.
|
Next generation sequencing (NGS) and single-cell sequencing technologies have enabled unparalleled resolution of the cell's molecular machinery; however, gleaning accurat [...]
2021 |
Abstract |
|
3.
|
Recently, longitudinal changes in human gut microbiome composition have been proposed to be more robust markers of host health than cross-sectional variation. However, it [...]
2024 |
Abstract |
|
4.
|
Acute Myeloid Leukemia (AML) is an aggressive cancer with poor overall survival due to frequent relapse. FMS-like tyrosine kinase (FLT3) is the most commonly mutated gene [...]
2022 |
Abstract |
|
5.
|
Patient stratification is essential for addressing breast cancer's inter- and intra-heterogeneity. While the PAM50 classifier is widely regarded to be the gold standard f [...]
2024-11-27 |
Thesis |
|
6.
|
The significant inter- and intra-tumor heterogeneity observed in breast cancer patients presents an ongoing challenge that impedes accurate disease characterization and c [...]
2024 |
Abstract |
|
7.
|
Immune checkpoint inhibitors have shown success in treating a subset of patients with certain late-stage cancers. However, these treatments fail in many other patients, d [...]
2024 |
Abstract |
|
8.
|
Immune checkpoint inhibitors have shown success in treating a subset of patients with certain late-stage cancers. However, these treatments fail in many other patients, d [...]
2023-08-18 |
Abstract |
|
9.
|
A major challenge in precision oncology is accurately modeling the molecular machinery that governs cellular sensitivity or resistance to a given drug or drug combination [...]
2020 |
Abstract |
|
10.
|
The work presented in this dissertation focuses on the development of robust deep learning models to predict in-vitro cancer drug responses, with utility in precision onc [...]
2024-09-19 |
Dissertation |
|